Norlase (private company)

See something wrong or missing? Let us know
Offices:
Copenhagen
Registration number:
35644547
Business model:
B2B
Investors:
we tracked 2 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 2 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Norlase is an ophthalmic medical device company developing next-generation laser solutions for the treatment of retina and glaucoma disease.

Companies with similar profile to Norlase:

CompanyCriteria
Norway Prediktor
54%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Particle 3D
54%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: West Hill Capital
  • Minim one investor from outside Scandinavia: Yes
Spain Rob Surgical
54%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Norway CardioMech
54%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Subcuject
46%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: Capnova
Denmark Cope IT
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Capnova
  • Minim one investor from outside Scandinavia: Yes
Denmark NMD Pharma
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Capnova
  • Minim one investor from outside Scandinavia: Yes
Denmark tiimo
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Capnova
  • Minim one investor from outside Scandinavia: Yes
Denmark Advalight
45%
  • Similar verticals: Manufacturing
  • Similar business models: B2B
  • At least one vc investor: Capnova
  • Total raised in a similar range: 5M - 10M USD
Denmark Resilio
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Capnova
  • Minim one investor from outside Scandinavia: Yes
Spain Devicare
44%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain Anaconda Biomed
44%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain Leuko
44%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Norway Curida
44%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Sweden Flow Neuroscience
44%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain Creat Sens
44%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain Qrem
44%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain Fesia Technology
44%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain MoWoot
44%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark Biograil
44%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes